BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 25714029)

  • 1. miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression.
    Zhang H; Qi S; Zhang T; Wang A; Liu R; Guo J; Wang Y; Xu Y
    Oncotarget; 2015 Mar; 6(8):6092-104. PubMed ID: 25714029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells.
    Jones DZ; Schmidt ML; Suman S; Hobbing KR; Barve SS; Gobejishvili L; Brock G; Klinge CM; Rai SN; Park J; Clark GJ; Agarwal R; Kidd LR
    BMC Cancer; 2018 Apr; 18(1):421. PubMed ID: 29653561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-195 suppresses tumor cell proliferation and metastasis by directly targeting BCOX1 in prostate carcinoma.
    Guo J; Wang M; Liu X
    J Exp Clin Cancer Res; 2015 Sep; 34(1):91. PubMed ID: 26338045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
    Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E
    BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-132-3p inhibits tumor malignant progression by regulating lysosomal-associated protein transmembrane 4 beta in breast cancer.
    Li S; Xu JJ; Zhang QY
    Cancer Sci; 2019 Oct; 110(10):3098-3109. PubMed ID: 31389121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
    Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
    Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-4638-5p inhibits castration resistance of prostate cancer through repressing Kidins220 expression and PI3K/AKT pathway activity.
    Wang Y; Shao N; Mao X; Zhu M; Fan W; Shen Z; Xiao R; Wang C; Bao W; Xu X; Yang C; Dong J; Yu D; Wu Y; Zhu C; Wen L; Lu X; Lu YJ; Feng N
    Oncotarget; 2016 Jul; 7(30):47444-47464. PubMed ID: 27329728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6(STAT6).
    Liu D; Tao T; Xu B; Chen S; Liu C; Zhang L; Lu K; Huang Y; Jiang L; Zhang X; Huang X; Zhang L; Han C; Chen M
    Biochem Biophys Res Commun; 2014 Feb; 445(1):151-6. PubMed ID: 24491557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition.
    Zhao Z; Zhao S; Luo L; Xiang Q; Zhu Z; Wang J; Liu Y; Luo J
    Br J Cancer; 2021 Mar; 124(5):982-994. PubMed ID: 33239676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-221-5p enhances cell proliferation and metastasis through post-transcriptional regulation of SOCS1 in human prostate cancer.
    Shao N; Ma G; Zhang J; Zhu W
    BMC Urol; 2018 Mar; 18(1):14. PubMed ID: 29506516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
    He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
    Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA miR-145-5p inhibits Phospholipase D 5 (PLD5) to downregulate cell proliferation and metastasis to mitigate prostate cancer.
    Liu J; Li J; Ma Y; Xu C; Wang Y; He Y
    Bioengineered; 2021 Dec; 12(1):3240-3251. PubMed ID: 34238129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-539 inhibits prostate cancer progression by directly targeting SPAG5.
    Zhang H; Li S; Yang X; Qiao B; Zhang Z; Xu Y
    J Exp Clin Cancer Res; 2016 Apr; 35():60. PubMed ID: 27037000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of miR-145-5p inhibits proliferation of prostate cancer cells and reduces SOX2 expression.
    Ozen M; Karatas OF; Gulluoglu S; Bayrak OF; Sevli S; Guzel E; Ekici ID; Caskurlu T; Solak M; Creighton CJ; Ittmann M
    Cancer Invest; 2015 Jul; 33(6):251-8. PubMed ID: 25951106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activin A regulates microRNAs and gene expression in LNCaP cells.
    Ottley EC; Nicholson HD; Gold EJ
    Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition.
    Wang L; Song G; Tan W; Qi M; Zhang L; Chan J; Yu J; Han J; Han B
    Oncotarget; 2015 Nov; 6(34):35978-90. PubMed ID: 26451614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-15b-5p facilitates the tumorigenicity by targeting RECK and predicts tumour recurrence in prostate cancer.
    Chen R; Sheng L; Zhang HJ; Ji M; Qian WQ
    J Cell Mol Med; 2018 Mar; 22(3):1855-1863. PubMed ID: 29363862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-296-5p (miR-296-5p) functions as a tumor suppressor in prostate cancer by directly targeting Pin1.
    Lee KH; Lin FC; Hsu TI; Lin JT; Guo JH; Tsai CH; Lee YC; Lee YC; Chen CL; Hsiao M; Lu PJ
    Biochim Biophys Acta; 2014 Sep; 1843(9):2055-66. PubMed ID: 24915000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-219-5p inhibits prostate cancer cell growth and metastasis by targeting HMGA2.
    Huang WT; Zhang H; Jin Z; Li K; Hu C; Li ML; Situ J
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4710-4718. PubMed ID: 32432734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers.
    Zheng B; Liang L; Huang S; Zha R; Liu L; Jia D; Tian Q; Wang Q; Wang C; Long Z; Zhou Y; Cao X; Du C; Shi Y; He X
    Oncogene; 2012 Oct; 31(42):4509-16. PubMed ID: 22179828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.